NEUTROGENA T/SAL THERAPEUTIC- salicylic acid shampoo 
Johnson & Johnson Consumer Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Neutrogena T/Sal Therapeutic Shampoo

Drug Facts

Active ingredient

Salicylic Acid 3.0%

Purpose

Anti-dandruff, anti-seborrheic dermatitis, anti-psoriasis

Use

Controls the symptoms of dandruff, seborrheic dermatitis and psoriasis.

Warnings

For external use only

Ask a doctor before use if you have a condition that covers a large area of the body.

When using this product avoid contact with eyes. If contact occurs, rinse eyes thoroughly with water.

Stop use and ask a doctor if condition worsens or does not improve after regular use of this product as directed.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

  • For best results, use at least twice a week or as directed by a physician
  • Wet hair thoroughly
  • Massage liberal amount of shampoo into the scalp
  • Leave lather on scalp for several minutes
  • Rinse and repeat

Inactive ingredients

Water
Cocamidopropyl Betaine
Sodium C14-16 Olefin Sulfonate
Linoleamidopropyl PG-Dimonium Chloride Phosphate
Sodium Lauroyl Sarcosinate
Polyquaternium-22
Hexylene Glycol
Sodium Citrate

Questions or comments?

Call 1-877-256-4247 (USA only). For more information go to: www.tgel.com

© Dist. by Neutrogena Corporation
Los Angeles, CA 90045

PRINCIPAL DISPLAY PANEL - 133 mL Carton

Neutrogena ®
T/SAL ®
therapeutic
shampoo

Scalp Build-Up
Control

clears and helps
prevent flakes and
scalp build-up

  • starts working after
    just one use
  • dandruff, psoriasis,
    seborrheic dermatitis

#1 DERMATOLOGIST
RECOMMENDED BRAND

NEUTROGENA ®

3% SALICYLIC ACID
4.5 FL OZ (133mL)

PRINCIPAL DISPLAY PANEL - 133 mL Carton
NEUTROGENA T/SAL  THERAPEUTIC
salicylic acid shampoo
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:10812-916
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID30 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
COCAMIDOPROPYL BETAINE (UNII: 5OCF3O11KX)  
SODIUM C14-16 OLEFIN SULFONATE (UNII: O9W3D3YF5U)  
LINOLEAMIDOPROPYL PROPYLENE GLYCOL-DIMONIUM CHLORIDE PHOSPHATE (UNII: 5Q87K461JO)  
SODIUM LAUROYL SARCOSINATE (UNII: 632GS99618)  
HEXYLENE GLYCOL (UNII: KEH0A3F75J)  
SODIUM CITRATE, UNSPECIFIED FORM (UNII: 1Q73Q2JULR)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:10812-916-021 in 1 CARTON10/12/201101/19/2023
1133 mL in 1 BOTTLE; Type 0: Not a Combination Product
2NDC:10812-916-0129 mL in 1 BOTTLE; Type 0: Not a Combination Product10/12/201105/13/2021
3NDC:10812-916-6712 in 1 CARTON10/12/201105/13/2021
329 mL in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart358H10/12/201101/19/2023
Labeler - Johnson & Johnson Consumer Inc. (002347102)

Revised: 5/2021
Document Id: c2c148c3-b2e0-46a7-e053-2995a90a6135
Set id: c67a7d3f-1aff-4753-a64a-d06618e2ddda
Version: 6
Effective Time: 20210520
 
Johnson & Johnson Consumer Inc.